The plasma ET-1 level in patients with liver disease has been shown to be higher than that in healthy subjects; therefore, the role of ET-1 in the liver has been discussed in contribution to the development and progression of liver diseases such as portal hypertension [28]. This evidence concerns the gene EDN1 and portal hypertension.